HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 06-27-2005, 10:37 AM   #1
Lisa
Guest
 
Posts: n/a
The grey box in the Tests and Trials section brings up a 2004 presentation by Dr. Carney with Bayer. It is an EXCELLENT description of HER2 from a clinical perspective.

Dr. Carney also explains the serum test and its monitoring procedure.

But my question, which I e-mailed Dr. Carney, is how this test can benefit me at this stage. His graphs clearly showed that the amount of Her2 in your system will affect your longevity. Since we currently have no option other than Herceptin for treatment, how would this test do anything but tell me whether my life expectancy is shorter than what I hoped?

I do hope he responds, and with his permission, I will share his response.

Love and light to all,

Lisa
  Reply With Quote
Old 06-27-2005, 10:37 PM   #2
StephN
Senior Member
 
StephN's Avatar
 
Join Date: Nov 2004
Location: Misty woods of WA State
Posts: 4,128
You pose an interesting question - can't wait to see what the answer will be.
I want to bring up this test with my med onc, but am already in a blood study trial at the U of W that tracks keratin-19. This study is coming up with some interesting results which may be ready for San Antonio this year.
StephN is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 09:53 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter